Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study

Vasiliki Mamakou, Eleftheria Zeggini, Eleni Zengini et al.|BMC Psychiatry|2018

Cited by 5